Robert Potashnick, Interim CFO of Envoy Medical Inc. ($COCH), made one open market purchase of common shares in the last year totaling $85,000, with the most recent on February 12, 2026. This ranks 2,547th among nearly 5,000 insiders averaging $1.46 million over 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Envoy Medical, Inc. | $COCH | Potashnick Robert | Interim CFO | P | Class A Common Stock | 212500 | $0.40 | 212,500.0000 | 21,851,606 | 9999.99% | 0.97% |
| Feb. 12, 2026 | Envoy Medical, Inc. | $COCH | Potashnick Robert | Interim CFO | P | Warrant (right to buy) | 127500 | $0.00 | 127,500.0000 | 21,851,606 | 9999.99% | 0.58% |
| Feb. 12, 2026 | Envoy Medical, Inc. | $COCH | Potashnick Robert | Interim CFO | P | Warrant (right to buy) | 212500 | $0.00 | 212,500.0000 | 21,851,606 | 9999.99% | 0.97% |
| Feb. 5, 2026 | Envoy Medical, Inc. | $COCH | Potashnick Robert | Interim CFO | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 21,851,606 | 9999.99% | 0.07% |